Clinical Trial Update: Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating irinotecan hydrochloride and cetuximab with or without ramucirumab in advanced colorectal cancer after progression on bevacizumab-conta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• IRINOTECAN HYDROCHLORIDE (irinotecan hydrochloride)
• Ramucirumab (ramucirumab)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-06-10